US clinical-stage biotech Keros Therapeutics (Nasdaq: KROS) has announced a strategic realignment designed to reallocate ...

Danish biotech Genmab (Nasdaq: GMAB) and US partner AbbVie (NYSE: ABBV) have reported a decisive win in a Phase III study of ...

Danish biotech Genmab (Nasdaq: GMAB) posted second-quarter revenue of $925 million, up 19% from a year earlier, driven by higher royalties from Johnson & Johnson’s (NYSE: JNJ) Darzalex (daratumumab) ...

The National Institute for Health and Care Excellence (NICE) has issued final guidance recommending Chiesi’s idebenone within ...

US artificial intelligence drug discovery firm Chai Discovery has secured $70 million in Series A funding, drawing backing ...

Eli Lilly (NYSE: LLY) posted a 38% jump in revenue to $15.6 billion in the second quarter of 2025, driven by surging demand ...

The Parkinson’s disease (PD) market across the seven major markets (7MM: USA, France, Germany, Italy, Spain, the UK and Japan ...

Shares of US clinical-stage company Eledon Pharmaceuticals shot up 9.9% to close at $3.44 yesterday, after it announced ...

The US Food and Drug Administration (FDA) has granted accelerated approval for Ireland-headquartered Jazz Pharmaceuticals’ ...

Merck & Co (NYSE: MRK) was the biggest spender in pharma M&A during July. The US pharma giant boldly splashed out around $10 ...

US pharma major Eli Lilly’s shares plunged more than 14% to $630.61 after it announced what was seen by the market ...

USA-based biotech DoveTree Medicines has signed a far-reaching partnership with Chinese drug discovery company XtalPi (HKEX: 2228), in a deal worth up to $5.99 billion.